Literaturverzeichnis

Albert U-S, Schulz K-D. Ökonomische und strukturelle Aspekte der Brustkrebsfrüherkennung. In: Schulz K-D, Albert U-S (Hrsg.). Stufe-3-Leitlinie Brustkrebsfrüherkennung in Deutschland. München, Wien, New York: Zuckschwerdt Verlag; 2003. 161.

Chen AM, Haffty BG, Lee CH. Local recurrence of breast cancer after breast conservation therapy in patients by means of stereotactic core-needle biopsy. Radiology 2002; 225: 707-712.

Chiarelli A, Doyle G, Kan L, Mah Z, et al. Report from the Evaluation Indicators Working Group: Guidelines for Monitoring Breast Screening Program Performance. Health Canada. Minister of Public Works and Goverment Sevices; 2002.

Collins LC, Conolly JL, Page DL, Goulart RA, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol 2004; 28: 126-131.

Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast? Am J Roentgenol 1999; 173 (5):1303-1313.

Groenewoud JH, Pijnappel RM, van den Akker-van Marle ME, Birnie E, et al. Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open breast biopsy. Br J Cancer 2004; 90: 383-392.

Hoorntje LE, Schipper ME, Kaya A, Verkooijen HM, Klinkenbijl JG, Rinkes IH. Tumour cell displacement after 14G breast biopsy. Eur J Surg Oncol 2004; 30 (5): 520-525.

Kassenärztliche Bundesvereinigung. Einführung eines bundesweiten Mammographie-Screening-Programms. Deutsches Ärzteblatt, Beilage 2004; Ausgabe A (4): 1-3.

King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM. Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 2001; 7 (1):19-24.

Kreienberg R, Kopp I, Lorenz W, Budach W, et al. Diagnostik, Therapie und Nachsorge des Mammakarzinoms der Frau: Eine nationale S3-Leitlinie. Deutsche Krebsgesellschaft e.V., Informations-zentrum für Standards in der Onkologie (ISTO), (Hrsg.). Frankfurt a. M.; 2004. http://leitlinien.net/ (Recherchedatum: 01.03.2005)

Lauterbach K (2004). Mammakarzinom-Verdacht: Zu viele diagnostische Operationen. Deutsches Ärzteblatt 2002; 45 (8. November): C-2377-2379.

Perry N, Broeders M, de Wolf C, Törnberg S, (Hrsg.). European guidelines for quality assurance in mammography screening. 3. Luxembourg: European Commission; 2001.

Rubin E, Mennemeyer S, Desmond RA, Urist MM, et al. Reducing the Cost of Diagnosis of Breast Carcinoma. Cancer 2001; 91: 324-332.

Rutgers EJT. Position Paper EUSOMA Guidelines: Quality control in the locoregional treatment of breast cancer. Eur J Cancer 2001; 37: 447-453.

Schulz K-D, Albert U-S, (Hrsg.). Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. München, Wien, New York: Zuckschwerdt Verlag; 2003.

Taxin A, Tartter PI, Zappetti D. Breast cancer diagnosis by fine needle aspiration and excisional biopsy. Recurrence and survival. Acta Cytol 1997; 41 (2): 302-306.

Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E. Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 2000; 41 (5):435-440.

Verkooijen HM on behalf of the COBRA Study Group. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 2002; 99: 853-859.